TY - JOUR
T1 - Trabeculectomy with 5-fluorouracil for adult inflammatory glaucoma
AU - Jampel, H. D.
AU - Jabs, D. A.
AU - Quigley, H. A.
PY - 1990
Y1 - 1990
N2 - We reviewed the records of 12 eyes of ten adult patients with inflammatory glaucoma who underwent trabeculectomy with the adjuvant use of 5-fluorouracil between January 1986 and January 1989. Intraocular pressure decreased from 36 ± 10 mm Hg (range, 17 to 50 mm Hg) preoperatively to 11 ± 4 mm Hg (range, 3 to 17 mm Hg) postoperatively after a median follow-up of 7.75 months (range, six to 38 months). All eyes achieved an intraocular pressure of <20 mm Hg, and ten of 12 required no intraocular pressure lowering medications. The mean (± S.D.) amount of 5-fluorouracil used was 33 ± 10 mg (range, 20 to 55 mg). During the period of observation, five of 12 eyes had an episode of uveitis, but in no patient did this result in loss of intraocular pressure control. Preoperative and postoperative systemic and topical corticosteroid use was the same. Trabeculectomy with 5-fluorouracil is an effective treatment for selected cases of adult inflammatory glaucoma refractory to medical management.
AB - We reviewed the records of 12 eyes of ten adult patients with inflammatory glaucoma who underwent trabeculectomy with the adjuvant use of 5-fluorouracil between January 1986 and January 1989. Intraocular pressure decreased from 36 ± 10 mm Hg (range, 17 to 50 mm Hg) preoperatively to 11 ± 4 mm Hg (range, 3 to 17 mm Hg) postoperatively after a median follow-up of 7.75 months (range, six to 38 months). All eyes achieved an intraocular pressure of <20 mm Hg, and ten of 12 required no intraocular pressure lowering medications. The mean (± S.D.) amount of 5-fluorouracil used was 33 ± 10 mg (range, 20 to 55 mg). During the period of observation, five of 12 eyes had an episode of uveitis, but in no patient did this result in loss of intraocular pressure control. Preoperative and postoperative systemic and topical corticosteroid use was the same. Trabeculectomy with 5-fluorouracil is an effective treatment for selected cases of adult inflammatory glaucoma refractory to medical management.
UR - https://www.scopus.com/pages/publications/0025095351
U2 - 10.1016/S0002-9394(14)75982-3
DO - 10.1016/S0002-9394(14)75982-3
M3 - Article
C2 - 2301528
AN - SCOPUS:0025095351
SN - 0002-9394
VL - 109
SP - 168
EP - 173
JO - American Journal of Ophthalmology
JF - American Journal of Ophthalmology
IS - 2
ER -